Table 4 |
||||
|
Breast cancer patients' pre-diagnosis and follow-ups functioning and symptoms scores as measured by the EORTC QLQ-BR23* (n = 99) |
||||
|
Baseline assessment |
3 months follow-up |
18 months follow-up |
P |
|
|
|
||||
|
Mean (SD) |
Mean (SD) |
Mean (SD) |
||
|
|
||||
|
Functioning |
||||
|
Body image |
86.2 (18.8) |
61.4 (34.4) |
60.8 (34.4) |
<0.001 |
|
Sexual functioning |
82.3 (22.4) |
74.5 (21.9) |
67.7 (26.4) |
<0.001 |
|
Sexual enjoyment |
51.6 (25.3) |
46.6 (25.1) |
23.3 (28.8) |
<0.001 |
|
Future perspective |
29.9 (29.5) |
36.0 (26.4) |
36.7 (29.1) |
<0.001 |
|
Symptoms+ |
||||
|
Arm symptoms |
7.7 (13.3) |
17.2 (16.5) |
24.8 (20.2) |
<0.001 |
|
Breast symptoms |
15.6 (15.0) |
10.2 (14.0) |
6.5 (9.7) |
<0.001 |
|
Systematic therapy side effects |
15.7 (11.8) |
29.2 (17.5) |
18.0 (13.7) |
<0.001 |
|
Upset by hair loss |
0.00 |
38.9 (38.9) |
50.0 (18.2) |
0.003 |
|
|
||||
|
* Scores range from 0 to 100, with higher scores representing a higher level of functioning. + Scores range from 0 to 100, with higher scores representing a higher level of symptoms. |
||||
|
Montazeri et al. BMC Cancer 2008 8:330 doi:10.1186/1471-2407-8-330 |
||||
